Clinical Trial Update: Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

The document reports on a Phase 1/2 study evaluating the safety and preliminary efficacy of combining iAPA-DC/CTL immunotherapy with gemcitabine in advanced pan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• iAPA-DC/CTL (iAPA-DC/CTL)

Snippet

Sponsor: Changhai Hospital | Conditions: Carcinoma, Pancreatic Ductal | Phase 1, Phase 2 | Status: UNKNOWN